US2016106104A1PendingUtilityA1
Silicone-based antimicrobial composition
Est. expiryMay 28, 2033(~6.9 yrs left)· nominal 20-yr term from priority
A01N 47/44A01N 43/50A01N 25/34
35
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates to a composition, comprising: at least one non-crosslinked silicone, and at least one antimicrobial agent dispersed within said silicone, said antimicrobial agent being selected from the group consisting of polymers of ionenes, and of ionic liquids with a molecular mass of less than 1,400 g/mol.
Claims
exact text as granted — not AI-modified1 . A composition, comprising:
at least one non-crosslinked silicone, and at least one antimicrobial agent dispersed within said silicone, said antimicrobial agent being selected from the group consisting of polymers of ionenes, and of ionic liquids with a molecular mass of less than 1,400 g/mol.
2 . The composition according to claim 1 , wherein the non-crosslinked silicone is a poly(dimethylsiloxane).
3 . The composition according to claim 1 , wherein the mass proportion of antimicrobial agent is from 1% to 10% based on the total mass of the composition.
4 . The composition according to claim 1 , wherein the antimicrobial agent is a poly(polymethylene) guanidine salt, comprising n recurrent units of formula (I-1):
wherein:
p is comprised from 2 to 12,
n is comprised from 4 to 140,
HA is selected from the group consisting of (CF 3 SO 2 ) 2 NH, HPF 6 and R—SO 3 H,
R is selected from the group consisting of C 4 -C 12 perfluoroalkyl groups and C 4 -C 10 aryl groups substituted with at least one group R′, and
R′ is selected from the group consisting of H; C 1 -C 18 alkyl groups; —NH—CO—R″ groups wherein R″ is a C 1 -C 17 alkyl group or a C 4 -C 10 aryl group; and groups —NH—SO 2 —C 6 H 4 —R′″ wherein R′″ is a hydrogen atom or a C 1 -C 6 alkyl group.
5 . The composition according to claim 4 , wherein n=6 and HA represents dodecylbenzenesulfonic acid of formula:
6 . The composition according to claim 1 , wherein the antimicrobial agent is a salt of poly(polymethylene)imidazolium, comprising n′ recurrent units of formula (I-2):
wherein:
m is comprised from 6 to 12,
n′ is comprised from 10 to 100, and
A − is selected from the group consisting of BF 4 − , PF 6 − and (CF 3 SO 2 ) 2 N − .
7 . The composition according to claim 1 , wherein the antimicrobial agent is an 1,3-dialkylimidazolium ionic liquid fitting the formula (II-1):
wherein:
A − is selected from the group consisting of BF 4 − , PF 6 − and (CF 3 SO 2 ) 2 N − ,
R 1 is a C 1 -C 16 alkyl group or a C 5 -C 16 alkylaryl group, and
R 2 is selected from the group consisting of C 4 -C 16 alkyl groups, C 5 -C 16 alkylaryl groups and groups of formula (II-1′):
wherein n″ is comprised from 6 to 12, R 1 and A − are as defined above.
8 . The composition according to claim 7 , wherein the antimicrobial agent is 1-octyl-3-methylimidazolinium tetrafluoroborate or 1-dodecyl-3-methylimidazolinium tetrafluoroborate.
9 . The composition according to claim 1 , wherein the antimicrobial agent is a guanidinium ionic liquid fitting the formula (II-2):
wherein:
R 1 represents a hydrogen atom or a C 12 -C 16 alkyl group,
R 2 represents a C 4 -C 16 alkyl group,
HA is selected from the group consisting of (CF 3 SO 2 ) 2 NH, HPF 6 and R—SO 3 H,
R is selected from the group consisting of C 4 - 12 perfluoroalkyl groups and C 4 -C 10 aryl groups substituted with a group R′, and
R′ is selected from the group consisting of H; C 1 -C 18 alkyl groups; —NH—CO—R″ groups wherein R″ is a C 1 -C 17 alkyl group or a C 4 -C 10 aryl group; and groups —NH—SO 2 —C 6 H 4 —R′″ wherein R′″ is a hydrogen atom or a C 1 -C 6 alkyl group.
10 . The composition according to claim 1 , wherein the antimicrobial agent is a phosphonium ionic liquid fitting the formula (II-3):
wherein:
R is a C 4 -C 12 alkyl group,
R′ is selected from the group consisting of C 2 -C 16 alkyl groups, C 5 -C 16 alkylaryl groups, and groups of formula (II-3′):
wherein n′″ is comprised from 6 to 12, R being as defined above, and
A − is selected from the group consisting of BF 4 − , (CF 3 SO 2 ) 2 N − , PF 6 − , P(O)(OR 1 ) 2 O − and R 2 —SO 3 − ,
R 1 is an alkyl group C 4 -C 8 ,
R 2 is selected from the group consisting of C 4 -C 12 perfluoroalkyl groups, C 8 -C 18 alkyl groups, and C 4 -C 10 aryl groups substituted with a group R 3 , and
R 3 is selected from the group consisting of H; C 1 -C 18 alkyl groups; —NH—CO—R 4 groups wherein R 4 is a C 1 -C 17 alkyl group or a C 4 -C 10 aryl group; and groups —NH—SO 2 —C 6 H 4 —R 5 wherein R 5 is a hydrogen atom or a C 1 -C 6 alkyl group.
11 . An antimicrobial article, comprising:
at least one crosslinked silicone, and at least one antimicrobial agent dispersed within said crosslinked silicone, said antimicrobial agent being as defined in claim 1 .
12 . The antimicrobial article according to claim 11 , having a desalting rate of the antimicrobial agent of less than 5% per year.Join the waitlist — get patent alerts
Track US2016106104A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.